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Table 1 Results of a 10-laboratory collaborative study to reassess quality control limits for cefotaxime disk susceptibility tests
Current quality control limits Observed zone diameters
No. zones
Control strain evaluateda Rangeb Midpoint Median (mm) % in range
Pseudomonas aeruginosa ATCC 27853 600 18–22 20 21 99.7%
Escherichia coli ATCC 25922 592 29–35 32 33 97.8%
Staphylococcus aureus ATCC 25923 580 25–31 28 28 98.6%
Haemophilus influenzae ATCC 49247 580 31–39 35 34 98.1%
Streptococcus pneumoniae ATCC 49619
NCCLS quality control limits 598 30–35 32.5 35 60.2%
Proposed range 598 31–39 35 35 96.3%
a Of the 600 determinations, some tests were excluded because the control disk gave zones outside of the established control ranges: for
different control strains, 3.3–0.3% of all cefotaxime zones were excluded. The control disk for the Streptococcus pneumoniae and Haemophilus
influenzae strains was cefixime, whereas cefaclor was the control disk for the Staphylococcus aureus and Escherichia coli strains. A
pseudomonas-active control disk could not be included because of space limitations. b Range of acceptable zone diameters (mm) listed in the
current NCCLS document, M100-S9 [2]. For Streptococcus pneumoniae ATCC 49619, an alternative control range is also listed. The midpoint
between the upper and lower limits is an idealized target value.
four of the five control strains were reconfirmed, since 98.1–
99.7% of the 600 zones fell within the established ranges and
the modal values were within 1 mm of the midpoint between
the two extremes. This included a narrow 5-mm range for P.
aeruginosa ATCC 27853 and a broader 9-mm range for H.
influenzae ATCC 49247. However, when S. pneumoniae ATCC
49619 was tested on Mueller–Hinton blood agar, only 60% of
the zones were within the narrow 6-mm range of 30–35 mm,
and the modal value was at the outer limit of 35 mm. The
current zone size limits are clearly inappropriate, and we pro-
pose a broader range of 31–39 mm for the S. pneumoniae control
strain. For that strain, other extended-spectrum cephalosporins
have 7- or 8-mm ranges [2], and this is compatible with the 9-
mm range that we are proposing for cefotaxime disk tests. Our
proposed change in zone size limits has recently been approved
by the NCCLS subcommittee on antimicrobial susceptibility
tests, and the new limits will appear in future NCCLS publi-
cations. This report describes the data that supported that
change in QC limits.
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Ascites and pleural effusion accompanying hepatitis A infection in
a child
Up to 1992, seven children were reported with acute hepatitis
A associated with ascites [1–3]. Pleural effusion also represents
a rare complication of acute type A viral hepatitis [4]. I report
a recent observation on a rare presentation of both ascites and
pleural effusion accompanying hepatitis A infection in a child.
A 4-year-old boy was hospitalized because of abdominal
distension and jaundice of the skin and sclerae. Four days earlier,
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he complained of headaches, anorexia, abdominal pain and
vomiting, and he developed a mild-to-moderate fever 2 days
later.
On initial physical examination, his temperature was
38.5 °C, his heart rate was 98 beats/min, and mild jaundice of
the skin and sclerae was present. The abdomen was distended,
and fluid was detected by abdominal percussion. The liver was
palpable 4 cm below the costal margin, but the spleen was not
palpable. There were no other abnormal findings in the physical
examination.
Laboratory values were as follows: total bilirubin 6 mg/dL,
direct bilirubin 2.4 mg/dL, aspartate aminotransferase
3660 U/L, alanine aminotransferase 2855 U/L, alkaline phos-
phatase 1306 U/L, lactate dehydrogenase 1010 U/L, urea nitro-
gen 23 mg/dL, creatinine 0.6 mg/dL, total protein 6.0 g/dL,
albumin 3.6 g/dL, sodium 134 mmol/L, potassium 4.1
mmol/L, serum amylase 22 U/L, a1-antitrypsin 3.8 g/L (normal
range 2.0–4.0 g/L), and ceruloplasmin 300 mg/L (normal range
150–550 mg/L). The results of urine analysis showed a +3 value
for bilirubin, increased levels of urobilinogen but no protein.
Sediment was normal. Both anti-HAVIgM and anti-HAVIgG
antibodies were detected. Hepatitis B surface antigen and anti-
bodies to hepatitis B, C and E were absent. Serologic analysis
for cytomegalovirus and Epstein–Barr virus revealed no evi-
dence of recent infection. Bilateral moderate pleural effusions
were shown on chest X-ray on the sixth day of hospitalization
but were not detected on initial chest radiogram. Abdominal
ultrasonography showed ascites. An ultrasound study 15 days
later showed complete resolution of both ascites and the pleural
effusion. Levels of liver transaminases became normal 1 month
later and the child recovered completely.
Ascites in liver diseases may occur as a result of venous and
lymphatic obstruction or decreases in the osmotic pressure of
plasma colloid, such as in hypoalbuminemia. A transient
increase in portal venous or lymphatic pressure due to the
compression of hepatic sinusoids may explain the occurrence
of ascites in this case. Pleural effusion may be secondary to ascites
due to fluid transport through the diaphragmatic lymphatics or
direct passage through a diaphragmatic defect. Our patient
developed bilateral pleural effusion 6 days after the diagnosis of
ascites associated with type A viral hepatitis.
In conclusion, ascites and pleural effusion may exceptionally
accompany hepatitis A infection in children, and presumably
the same may occur in adults. Its appearance, however, does
not indicate an unfavorable outcome.
F. Gu¨rkan
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Disseminated Nocardia asteroides complex infection in an immuno-
compromised child
Nocardiosis is a rather frequent infectious disease that usually
involves the respiratory tract [1–5]. Predisposing factors include
malignancies, AIDS, organ transplantation, tuberculosis, drugs
or alcohol abuse, lupus erythematosus, diabetes and chronic
lung disease [2,4]. Very few cases have been reported in Greece,
therefore we report a case of pulmonary nocardiosis in an 8-
year-old immunocompromised female.
The girl was admitted to our hospital because of fever and
cough. She had been suffering from autoimmune hemolytic
anemia and thrombopenia (Evans’s syndrome) from the age of
1 year, receiving corticosteroids and cyclosporin periodically. A
Mycobacterium avium complex (MAC) disseminated infection
had taken place a year ago, which was treated with a com-
bination of ethambutol, rifampicin, cycloserine and cla-
rithromycin.
On admission, the laboratory studies showed WBC count
of 27800/mL, with 87% neutrophils, haemoglobin 17.6 g/dL,
erythrocytes sedimentation rate (ESR) 15 mm/h, CRP
55 mg/L, AST 62 U/L and ALT 64 U/L, urine protein
300 mg/dL with a few granular and rare waxy casts in the
urinalysis. Blood and urine cultures were sterile and exclusive
growth of Candida albicans was found in fecal cultures. The
main roentgenographic findings included a centrally placed
circumscribed shadow in the left middle lobe with mediastinal
lymph node enlargement to the same side. Candida albicans was
isolated in urine culture 2 weeks after the admission. Some
subcutaneous scalp abscesses were noted 1 month after the
admission and the ESR had increased to 110 mm/h.
Nocardia asteroides complex (NAC) was then isolated from
blood, sputum and the exudate of the subcutaneous abscesses.
The initial Gram stain preparations revealed Gram-positive,
beaded, partially acid-fast, branched filaments. An empirical
course of treatment was given, which consisted of amikacin,
trimethoprim-sulfamethoxazole and ceftriaxone. In the fol-
lowing days a final identification of NAC was made, based on
colony morphology and biochemical characteristics [4]. The
susceptibility testing was performed by a modified disk diffusion
